China Traditional Chinese Medicine Holdings Future Growth
Future criteria checks 3/6
China Traditional Chinese Medicine Holdings is forecast to grow earnings and revenue by 12.3% and 16.4% per annum respectively. EPS is expected to grow by 12.5% per annum. Return on equity is forecast to be 11.5% in 3 years.
Key information
12.3%
Earnings growth rate
12.5%
EPS growth rate
Pharmaceuticals earnings growth | 12.7% |
Revenue growth rate | 16.4% |
Future return on equity | 11.5% |
Analyst coverage | Low |
Last updated | 24 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 30,738 | 1,851 | 713 | N/A | 2 |
12/31/2025 | 25,184 | 1,633 | 567 | N/A | 4 |
12/31/2024 | 22,357 | 1,358 | 295 | N/A | 3 |
12/31/2023 | 18,122 | 1,285 | N/A | N/A | N/A |
9/30/2023 | 17,909 | 1,107 | N/A | N/A | N/A |
6/30/2023 | 17,696 | 929 | -332 | 222 | N/A |
3/31/2023 | 16,000 | 847 | 117 | 657 | N/A |
12/31/2022 | 14,304 | 764 | 566 | 1,092 | N/A |
9/30/2022 | 15,560 | 1,090 | 512 | 1,119 | N/A |
6/30/2022 | 16,815 | 1,417 | 458 | 1,146 | N/A |
3/31/2022 | 17,934 | 1,675 | 188 | 971 | N/A |
12/31/2021 | 19,053 | 1,933 | -81 | 796 | N/A |
9/30/2021 | 17,677 | 1,897 | 374 | 1,372 | N/A |
6/30/2021 | 16,300 | 1,861 | 829 | 1,948 | N/A |
3/31/2021 | 15,553 | 1,762 | -73 | 1,088 | N/A |
12/31/2020 | 14,806 | 1,663 | -975 | 228 | N/A |
9/30/2020 | 14,423 | 1,562 | -334 | 723 | N/A |
6/30/2020 | 14,039 | 1,461 | 308 | 1,218 | N/A |
3/31/2020 | 14,180 | 1,525 | 477 | 1,401 | N/A |
12/31/2019 | 14,321 | 1,588 | 646 | 1,585 | N/A |
9/30/2019 | 13,528 | 1,563 | 237 | 1,341 | N/A |
6/30/2019 | 12,735 | 1,538 | -173 | 1,097 | N/A |
3/31/2019 | 11,997 | 1,488 | 26 | 1,144 | N/A |
12/31/2018 | 11,259 | 1,439 | 224 | 1,190 | N/A |
9/30/2018 | 10,579 | 1,386 | 326 | 1,103 | N/A |
6/30/2018 | 9,900 | 1,332 | 428 | 1,016 | N/A |
3/31/2018 | 9,119 | 1,251 | 530 | 1,126 | N/A |
12/31/2017 | 8,338 | 1,170 | 633 | 1,236 | N/A |
9/30/2017 | 7,785 | 1,123 | N/A | 419 | N/A |
6/30/2017 | 7,233 | 1,075 | N/A | -397 | N/A |
3/31/2017 | 6,883 | 1,021 | N/A | 534 | N/A |
12/31/2016 | 6,533 | 967 | N/A | 1,465 | N/A |
9/30/2016 | 6,010 | 880 | N/A | 1,248 | N/A |
6/30/2016 | 5,487 | 794 | N/A | 1,031 | N/A |
3/31/2016 | 4,598 | 670 | N/A | 775 | N/A |
12/31/2015 | 3,709 | 546 | N/A | 519 | N/A |
9/30/2015 | 3,271 | 509 | N/A | N/A | N/A |
6/30/2015 | 2,833 | 471 | N/A | 397 | N/A |
3/31/2015 | 2,742 | 444 | N/A | 361 | N/A |
12/31/2014 | 2,650 | 417 | N/A | 325 | N/A |
9/30/2014 | 2,384 | 370 | N/A | N/A | N/A |
6/30/2014 | 2,117 | 324 | N/A | 176 | N/A |
3/31/2014 | 1,756 | 261 | N/A | 131 | N/A |
12/31/2013 | 1,395 | 198 | N/A | 85 | N/A |
9/30/2013 | 1,233 | 183 | N/A | 92 | N/A |
6/30/2013 | 1,082 | 170 | N/A | 101 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 570's forecast earnings growth (12.3% per year) is above the savings rate (2.2%).
Earnings vs Market: 570's earnings (12.3% per year) are forecast to grow faster than the Hong Kong market (12.1% per year).
High Growth Earnings: 570's earnings are forecast to grow, but not significantly.
Revenue vs Market: 570's revenue (16.4% per year) is forecast to grow faster than the Hong Kong market (8.1% per year).
High Growth Revenue: 570's revenue (16.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 570's Return on Equity is forecast to be low in 3 years time (11.5%).